Zhou, Z., Nath, R., Cerny, J., Wang, H., Zhang, M., Abdel-Azim, H., . . . Saber, W. (2020). Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: A CIBMTR report. Blood Adv.
Style de citation ChicagoZhou, Zheng, et al. "Reduced Intensity Conditioning for Acute Myeloid Leukemia Using Melphalan- Vs Busulfan-based Regimens: A CIBMTR Report." Blood Adv 2020.
Style de citation MLAZhou, Zheng, et al. "Reduced Intensity Conditioning for Acute Myeloid Leukemia Using Melphalan- Vs Busulfan-based Regimens: A CIBMTR Report." Blood Adv 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.